Biophytis Presented Positive Results of Phase 2-3 COVA Study At The American Thoracic Society International Conference

Biophytis SA announces that it presented the positive results of the phase 2-3 COVA study with Sarconeos in severe COVID-19 at the American Thoracic Society International Conference that was held in Washington DC between the 19th and 24th of May 2023.

Scroll to Top